CAMPATH vs COPIKTRA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. CAMPATH and COPIKTRA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAMPATH	COPIKTRA
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ALEMTUZUMAB	DUVELISIB
Manufacturer	Genzyme	Secura
Dosage forms	Injectable	Capsule
Drug class	Cd52-Directed Cytolytic Antibody	—
Boxed warning	Boxed warning	Boxed warning
Treats	B-Cell Chronic Lymphocytic Leukemia	B-Cell Chronic Lymphocytic Leukemia

campath copiktra

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

ALEMTUZUMAB

DUVELISIB

Manufacturer

Genzyme

Secura

Dosage forms

Injectable

Capsule

Drug class

Cd52-Directed Cytolytic Antibody

—

Boxed warning

Treats

B-Cell Chronic Lymphocytic Leukemia

Frequently asked questions

What is the difference between Campath and Copiktra?

Campath contains Alemtuzumab, while Copiktra contains Duvelisib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.